PROGESTERONE RECEPTOR IN BREAST DEVELOPMENT AND CANCER
孕酮受体在乳房发育和癌症中的作用
基本信息
- 批准号:6965687
- 负责人:
- 金额:$ 31.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-04-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:RNase protection assayapoptosisbiological signal transductionbreast neoplasmscarcinogenesiscell proliferationcyclinsepidermal growth factorgene targetinggenetically modified animalsgenotypegreen fluorescent proteinshistogenesishistopathologyhormone related neoplasm /cancerimmunocytochemistrylaboratory mousemammary epitheliummammary glandphenotypeprogesterone receptors
项目摘要
DESCRIPTION (provided by applicant): Considering the importance of the progesterone (P)-proliferative signal to mammary development and tumorigenesis, our long-term goal is to exploit experimental mouse genetics to gain a more mechanistic understanding of P's role as an endocrine mammogen, in vivo. Toward this end, our recent studies revealed that in the proliferating murine mammary gland, the majority of PR positive (+) cells were surprisingly nonproliferative but were in close association with a subgroup of PR negative (-) cells which proliferate in response to P; a similar cellular organization pattern for PR expression occurs in the human and rat mammary gland. Importantly, derailment of this distinct patterning for mammary PR expression is linked to a number of aberrant mammary growth phenotypes, including neoplasia. The foregoing observations strongly support our hypothesis of an evolutionary conserved cellular mechanism for P-action in the normal gland in which PR+ cells receive, transduce, and then relay (via a paracrine pathway) the P-proliferative signal to neighboring PR- cells, which are then directed toward a pathway of proliferation. Our hypothesis predicts the existence of an intraepithelial paracrine molecular pathway(s), which mediates the P-proliferative signal; the Wnt-4 pathway has been implicated as such a pathway. To test our hypothesis, Specific Aim 1 will employ our PR-LacZ reporter mouse, a recently generated PR-enhanced green fluorescent protein knockin mouse, fluorescence-activated cell sorting, and mammary epithelial transplantation approaches to query-at the cellular level-the functional importance of P's proposed paracrine mechanism of action in the normal mammary gland. Specific Aim 2 will define the developmental importance of PR expression during early mammary development to PR's function in the adult gland by using the tetracycline regulated expression system (the TET-ON system) to temporally control PR expression in the mammary epithelium of the PR knockout (PRKO) mouse. Using the TET-ON system and the PRKO, Specific Aim 3 will address whether Wnt-4 is a bona-fide paracrine mediator of the P-proliferative signal in the murine mammary gland. Finally, Specific Aim 4 will employ comparative transcriptional profiling of normal and PRKO mammary glands to identify the complete spectrum of paracrine mediators of the P-mammary signal. Application of microarray approaches to murine mammary tumor models (developed during the last grant period) will also uncover signature gene-networks specific for either hormone-dependent or -independent breast tumors; this aim should also furnish important molecular targets for future breast cancer diagnosis, prognosis and/or therapy.
描述(由申请人提供):考虑到孕酮(P)-增殖信号对乳腺发育和肿瘤发生的重要性,我们的长期目标是利用实验小鼠遗传学来获得对P作为体内内分泌乳腺激素的作用的更机械的理解。为此,我们最近的研究表明,在增殖的小鼠乳腺中,大多数PR阳性(+)细胞令人惊讶的是非增殖性的,但与一个亚组的PR阴性(-)细胞,增殖响应P密切相关; PR表达的细胞组织模式相似,发生在人类和大鼠乳腺。重要的是,乳腺PR表达的这种独特模式的脱轨与许多异常的乳腺生长表型有关,包括肿瘤形成。上述观察结果强烈支持我们的假设,即在正常腺体中P-作用的进化保守的细胞机制,其中PR+细胞接收、传递,然后(通过旁分泌途径)将P-增殖信号传递给相邻的PR-细胞,然后将其导向增殖途径。我们的假设预测存在上皮内旁分泌分子通路,其介导P-增殖信号; Wnt-4通路被认为是这样的通路。为了验证我们的假设,具体目标1将采用我们的PR-LacZ报告小鼠,最近产生的PR增强的绿色荧光蛋白敲入小鼠,荧光激活细胞分选,和乳腺上皮移植的方法来查询-在细胞水平上的功能的重要性P的建议旁分泌作用机制在正常乳腺。具体目标2将通过使用四环素调节的表达系统(TET-ON系统)暂时控制PR敲除(PRKO)小鼠乳腺上皮中的PR表达,定义早期乳腺发育期间PR表达对PR在成年腺体中的功能的发育重要性。使用TET-ON系统和PRKO,特异性目标3将解决Wnt-4是否是鼠乳腺中P-增殖信号的真正旁分泌介体。最后,具体目标4将采用正常和PRKO乳腺的比较转录谱来鉴定P-乳腺信号的旁分泌介质的完整谱。微阵列方法应用于小鼠乳腺肿瘤模型(在最后一次资助期间开发)也将揭示对乳腺癌依赖性或非依赖性乳腺肿瘤特异性的特征基因网络;这一目标也将为未来的乳腺癌诊断、预后和/或治疗提供重要的分子靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN P LYDON其他文献
JOHN P LYDON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN P LYDON', 18)}}的其他基金
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
- 批准号:31970691
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
- 批准号:31900527
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
姜黄素与TRAIL的协同抗肿瘤机制研究
- 批准号:31101223
- 批准年份:2011
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
- 批准号:81100502
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Causes and Downstream Effects of 14-3-3 Phosphorylation in Synucleinopathies
突触核蛋白病中 14-3-3 磷酸化的原因和下游影响
- 批准号:
10606132 - 财政年份:2024
- 资助金额:
$ 31.88万 - 项目类别:
Role of Frizzled 5 in NK cell development and antiviral host immunity
Frizzled 5 在 NK 细胞发育和抗病毒宿主免疫中的作用
- 批准号:
10748776 - 财政年份:2024
- 资助金额:
$ 31.88万 - 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 31.88万 - 项目类别:
The Gut as a Target to Improve Outcomes in Sepsis
肠道作为改善脓毒症预后的目标
- 批准号:
10552403 - 财政年份:2023
- 资助金额:
$ 31.88万 - 项目类别:
The role of BET proteins in pathological cardiac remodeling
BET蛋白在病理性心脏重塑中的作用
- 批准号:
10538142 - 财政年份:2023
- 资助金额:
$ 31.88万 - 项目类别:
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 31.88万 - 项目类别:
The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
- 批准号:
10404415 - 财政年份:2023
- 资助金额:
$ 31.88万 - 项目类别:
Functional role of Sec20, a BH3 and Secretory (Sec) domain protein, in neurons and its relevance to a motor neuron disease in Drosophila
Sec20(一种 BH3 和分泌 (Sec) 结构域蛋白)在神经元中的功能作用及其与果蝇运动神经元疾病的相关性
- 批准号:
10635856 - 财政年份:2023
- 资助金额:
$ 31.88万 - 项目类别:
Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme
使用 MRI 引导聚焦超声联合 5-氨基乙酰丙酸的声动力疗法治疗复发性多形性胶质母细胞瘤
- 批准号:
10699858 - 财政年份:2023
- 资助金额:
$ 31.88万 - 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 31.88万 - 项目类别:














{{item.name}}会员




